Phasing and Linking Long Fragment Reads for Genomic Variation Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current pre-implantation genetic diagnosis (PGD) methods for in vitro fertilization (IVF) are inadequate in detecting de novo mutations and variations not associated with specific diseases, missing many genomic defects and failing to improve the health of IVF newborns, as they primarily focus on large genomic alterations or single-gene disorders.

Innovation Solution

The implementation of phasing and linking processes using long fragment reads (LFR) to identify haplotypes and resolve base calls, allowing for the accurate detection of hemizygous deletions, insertions, and other variations by utilizing shared labels and phasing rates, thereby improving the identification of genomic defects in embryos.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current PGD methods are used to detect large genomic alterations or single-gene disorders, then the diagnostic process is simple and fast, but many genomic defects including de novo mutations are missed

Engineering Contradiction:
Improvedetection accuracyVSAvoiddiagnostic process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The diagnostic process is segmented into multiple stages: initial screening for large genomic alterations, followed by whole genome sequencing for comprehensive variant detection, and finally bioinformatic analysis to identify de novo mutations. This segmentation allows the system to achieve high detection accuracy while managing complexity through structured workflow

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The method performs preliminary whole genome sequencing and bioinformatic filtering to identify potential de novo mutations before final diagnostic confirmation. This preliminary action enables the detection of previously undetectable variants while maintaining diagnostic efficiency through pre-screening

Inventive Principle:
Principle #10Preliminary action

2Reliability

If comprehensive whole genome sequencing is performed to detect all genomic variations, then detection accuracy improves, but the cost and time required increase significantly

Engineering Contradiction:
Improvedetection accuracyVSAvoiddiagnostic time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The system performs preliminary bioinformatic filtering to identify de novo mutations and high-priority variants before comprehensive diagnostic analysis. This preliminary action reduces the time required by focusing subsequent detailed analysis only on relevant findings rather than processing all genomic data equally

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The diagnostic process incorporates feedback loops where initial sequencing results guide subsequent analysis priorities. If de novo mutations are detected, the system automatically prioritizes further investigation of those specific variants, reducing overall diagnostic time while maintaining comprehensive coverage

Inventive Principle:
Principle #23Feedback

3Reliability

If current PGD methods are used, then the process is cost-effective, but the ability to identify de novo mutations and improve IVF newborn health is limited

Engineering Contradiction:
Improvehealth outcome improvementVSAvoidresource consumption
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The system performs preliminary identification of de novo mutations through bioinformatic analysis of whole genome sequencing data. This preliminary action enables targeted intervention only when necessary, improving health outcomes while avoiding unnecessary resource consumption in cases where no de novo mutations are present

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The diagnostic approach changes parameters by transitioning from targeted analysis of specific genes to comprehensive whole genome sequencing. This parameter change enables detection of any genomic variation including de novo mutations, thereby improving health outcome prediction while the bioinformatic filtering manages resource requirements

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS10468121B2Phasing and linking processes to identify variations in a genome
Publication Date: 2019.11.05 MGI TECH CO LTD
  • US10468121B2 patent drawing
  • US10468121B2 patent drawing
  • US10468121B2 patent drawing

AI summary

Long fragment read techniques can be used to identify deletions and resolve base calls by utilizing shared labels (e.g., shared aliquots) of a read with any reads corresponding to heterozygous loci (hets) of a haplotype. For example, the linking of a locus to a haplotype of multiple hets can increase the reads available at the locus for determining a base call for a particular haplotype. For a hemizygous deletion, a region can be linked to one or more hets, and the labels for a particular haplotype can be used to identify which reads in the region correspond to which haplotype. In this manner, since the reads for a particular haplotype can be identified, a hemizygous deletion can be determined. Further, a phasing rate of pulses can be used to identify large deletions. A deletion can be identified with the phasing rate is sufficiently low, and other criteria can be used.